67-year-old male with colon cancer and ground-glass opacities. CHEST:LUNGS AND PLEURA: Reference lesion behind right main stem bronchus is slightly increased in size. It currently measures 27 x 27 mm, previously 26 x 26 (image 39 series 3). Other lung nodules have significantly increased in size. Specifically two right lower lobe nodules. One currently measures 27 x 21 mm, previously 22 x 18 (image 47 series 4). Another currently measures 15 x 12 mm, previously 7 x 7 mm (image 43 series 4). Near resolution of bilateral ground-glass opacities. MEDIASTINUM AND HILA: Reference precarinal lymph node is unchanged and currently measures 19 x 14, previosuly19 x 14 mm (image 32 series 3). Coronary artery calcifications. CHEST WALL: Right sided port with catheter tip at aortocaval junction. Sternotomy wires are noted. ABDOMEN:LIVER, BILIARY TRACT: No significant abnormality notedSPLEEN: No significant abnormality notedPANCREAS: Calcification the pancreatic tail, unchanged.ADRENAL GLANDS: No significant abnormality notedKIDNEYS, URETERS: Right renal stone without evidence of hydronephrosis is unchanged.RETROPERITONEUM, LYMPH NODES: Reference aortocaval lymph node measures 22 x 17mm, previously, 22 x 19 mm.BOWEL, MESENTERY: Mild wall thickening of the small bowel segments in the pelvis likely secondary to radiation is unchanged. Small wide mouth ventral hernia containing nonobstructive bowel segments is unchanged.BONES, SOFT TISSUES: Degenerative changes are noted. OTHER: No significant abnormality notedPELVIS:PROSTATE, SEMINAL VESICLES: No significant abnormality notedBLADDER: No significant abnormality notedLYMPH NODES: Reference left external iliac lymph node is unchanged measuring 14 x 8 mm previously 13 x 8 mm (image 179 series 3).BOWEL, MESENTERY: Rectal anastomoses again identified.BONES, SOFT TISSUES: No significant abnormality notedOTHER: No significant abnormality noted
1. While minimal change in the reference lung masses, there are substantial increase in size in several other lung nodules.2. No significant change in size of retroperitoneal lymph node size. 3. Interval improvement in ground-glass opacities. 